Cytel’s Advances in RWD Include Comparative Effectiveness and Efficacy Assessments Using Target Trial Emulation Solution
Real world data (RWD) is attractive to many stakeholders as it offers a time- and cost-saving method to complement or [...]
HealthVerity’s 76 RWD Sources Inform COVID-19 Booster Shot Discussion
In an effort to understand how variants respond to COVID-19 vaccines, researchers are turning to real world data (RWD), such [...]
Study Highlights Use of RWD and Data Analytics to Identify High-Risk Prostate Cancer Patients
Researchers at the University of Michigan used real world data (RWD) and data analytics to determine which prostate cancer patients [...]
Register for Upcoming ISPOR Signal Event on Current HEOR Trends and Applying New Big Data Tools
Register today for a virtual ISPOR event that will take place from 11:00 AM to 12:30 PM EDT on September [...]
RWE Whitepaper Discusses Using EMRs and HIE Technology to Gain Insight Into Patient Outcomes
A whitepaper published in Evidera’s The Evidence Forum discusses real world evidence (RWE) applications in determining patient outcomes. The article [...]
RWD Powerhouse OM1 Announces $85 Million in Financing to Personalize Healthcare and Target Chronic Diseases
Real world data (RWD) company OM1 has announced $85 million in financing. The company uses RWD to develop personalized treatments [...]
Aetion and Cegedim Health to Continue Rewarding RWD Partnership to Track Medication Efficacy and Safety
Aetion and Cegedim Health have announced that they will continue their real world data (RWD) partnership. The collaboration combines Aetion’s [...]
The Patient Centered Outcomes Research Institute Awards $259 Million in Comparative Effectiveness Research Projects, New Principles Include Utilizing RWD and Improving Equity
The Patient Centered Outcomes Research Institute (PCORI) was established more than a decade ago to improve patient-centered research. The institute provides [...]
Harvard Scientist Discusses Maintaining Transparency and Reproducibility in RWE Studies
Dr. Shirley Wang shared her thoughts on how to overcome obstacles associated with real world evidence (RWE) studies. She notes [...]
Upcoming ISPOR Webinar on NICE’s Modernized Data Handling Methods and 5-Year Strategy
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) will hold a virtual event on July 15th at 11:00 AM [...]
Cures 2.0 Key Points Include New $6.5 Billion Federal Research Agency and Expanded RWD in Clinical Trials
Cures 2.0 was introduced on June 22nd. The proposed bipartisan legislation includes components that center on diversifying clinical trials and [...]
Expanded Cures 2.0 Legislation Considers Patient Access and Broadened Use of RWD in Clinical Trials
A recent article, published by the Regulatory Affairs Professionals Society (RAPS), notes that a discussion draft meant to further the [...]
Register Today for Upcoming ISPOR Webinar on Using RWD to Improve Oncology Research and Patient Outcomes in China
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) will host a webinar on June 29th, 2021, at 11:00 AM [...]
Thursday Webinar on Incorporating SDoH RWD to Improve R&D and Support Outreach Efforts
A webinar on understanding and effectively using social determinants of health (SDoH) data will take place on Friday, June 24th [...]
Register Today for Upcoming AMCP Webinar on the Biosimilar Landscape in the United States
The Academy of Managed Care Pharmacy (AMCP) will host a virtual event on biosimilars. The webinar will detail steps than [...]
Google Data Used in Vaccine Equity Planner Tool to Identify COVID-19 Vaccine Deserts
Google has released its COVID-19 vaccination data on github, updated weekly to reflect changes in vaccination locations and availability. The [...]
RWE Alliance Includes Five Leading Organizations
Five companies have partnered to form the RWE Alliance, a collaboration intended to advance the use of real world evidence [...]
xCures Opens Artificial Intelligence xINFORM Platform Early to Inform Cancer Patient Care
xCures has announced early access for its xINFORM platform. The free platform is designed to identify personalized treatments for late-stage [...]
[Article] Industry Leaders Provide Updated RWE Guidelines; Aetion and Amgen Experts Among Authors
A recent article, published in the Journal of Comparative Effectiveness Research, provides an updated look into the state of real [...]
OPEN Health Experts Discuss Healthcare Industry Trends Including Market Access Challenges, HEOR Insights, and RWE Focus; Greater Emphasis on Patient Voice Needed
HealthEconomics.Com welcomed CEO of Evidence and Access Dr. Jeff Anderson and Senior Director of Strategic Market Access Dr. Rosemary Jose [...]
Syapse and Pfizer Experts Discuss Identifying High Quality RWD to Generate RWE
In a recent discussion, Syapse’s Thomas Brown and Alissa Winzeler-Cotton, along with Pfizer’s Manuela Di Fusco and Orazio Caffo of [...]
Clarivate Executive Brief Discusses Using RWD to Understand the Patient Journey
An executive brief released by Clarivate details the data sources that allow various stakeholders to understand the patient journey. It [...]
IQVIA Blog Post on RWE Considerations in Drug Development Pipeline
Real world evidence (RWE) experts at IQVIA shared their thoughts on when it’s appropriate to use RWE during the drug [...]
Discussion on the Power of RWE in Drug Development and Market Access
Aetion invited two leaders in real world evidence (RWE) to share their thoughts on industry trends. Chief Data Science Officer [...]
Aetion Discussion on RWE Solutions for Providers and Payers
Aetion’s Senior Vice President of Payer Solutions William Guptail discusses how real world evidence (RWE) can inform both payer and [...]